))
Digital Politics with Karen Jagoda is a non-partisan podcast featuring thought leaders and industry pioneers with insights about innovative approaches to political campaigns, voter engagement, mobilization, fundraising, persuasion, and GOTV. Topics include the power of mobile devices, leveraging social networks, message testing and targeting, cross-media advertising, grassroots organizing, and big data.
…
continue reading
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
D
Digital Politics with Karen Jagoda
1
The Path to Regulation of Psychedelic Therapies with Dr. Joe Tucker Enveric Biosciences
19:25
19:25
Play later
Play later
Lists
Like
Liked
19:25
Dr. Joe Tucker, CEO of Enveric Biosciences, shines a light on the challenges of those working with psychedelic therapies to inform legislators about the need for regulation to gain acceptance for the use of these molecules for medicinal purposes. In this era of increasing mental health awareness and neurodegenerative diseases, research on the uniqu…
…
continue reading
E
Empowered Patient Podcast
1
Improving Utilization of Structured and Unstructured Healthcare Data with Ivana Naeymi-Rad Intelligent Medical Objects TRANSCRIPT
Ivana Naeymi-Rad, Chief Operating Officer at Intelligent Medical Objects, works with providers, payers, and life science companies to help them make sense of data. IMO specializes in data quality, cleaning paper-based data, and data interoperability in structured and unstructured formats. Sentiment analysis provides insights into the emotions of pr…
…
continue reading
E
Empowered Patient Podcast
1
Improving Utilization of Structured and Unstructured Healthcare Data with Ivana Naeymi-Rad Intelligent Medical Objects
18:48
18:48
Play later
Play later
Lists
Like
Liked
18:48
Ivana Naeymi-Rad, Chief Operating Officer at Intelligent Medical Objects, works with providers, payers, and life science companies to help them make sense of data. IMO specializes in data quality, cleaning paper-based data, and data interoperability in structured and unstructured formats. Sentiment analysis provides insights into the emotions of pr…
…
continue reading
E
Empowered Patient Podcast
1
Value of Real-World Data in Oncology Drug Development and Clinical Trials with Vasu Chandrasekaran Ontada TRANSCRIPT
Vasu Chandrasekaran, VP of real-world data and analytics at Ontada, provides an electronic health record platform, iKnowMed, used by community oncology providers to practice evidence-based and patient-centered medicine better. They also work closely with the US Oncology Network to improve access to new therapies and clinical trials. Using real-worl…
…
continue reading
E
Empowered Patient Podcast
1
Value of Real-World Data in Oncology Drug Development and Clinical Trials with Vasu Chandrasekaran Ontada
19:25
19:25
Play later
Play later
Lists
Like
Liked
19:25
Vasu Chandrasekaran, VP of real-world data and analytics at Ontada, provides an electronic health record platform, iKnowMed, used by community oncology providers to practice evidence-based and patient-centered medicine better. They also work closely with the US Oncology Network to improve access to new therapies and clinical trials. Using real-worl…
…
continue reading
E
Empowered Patient Podcast
1
Real-Time MRI-Guided Incision-Free Treatment for Prostate Cancer with Arun Menawat Profound Medical TRANSCRIPT
Arun Menawat, CEO of Profound Medical, discusses the challenges of treating prostate cancer and how traditional treatments like prostate removal or radiation often result in side effects and complications. While historically, a PSA blood test has been used for diagnosis, an MRI provides a more precise and efficient diagnostic tool. In addition, Pro…
…
continue reading
E
Empowered Patient Podcast
1
Real-Time MRI-Guided Incision-Free Treatment for Prostate Cancer with Arun Menawat Profound Medical
19:13
19:13
Play later
Play later
Lists
Like
Liked
19:13
Arun Menawat, CEO of Profound Medical, discusses the challenges of treating prostate cancer and how traditional treatments like prostate removal or radiation often result in side effects and complications. While historically, a PSA blood test has been used for diagnosis, an MRI provides a more precise and efficient diagnostic tool. In addition, Pro…
…
continue reading
E
Empowered Patient Podcast
1
Power of Real-World Data in Research and Clinical Practice with Dr. Michael Mbagwu Verana Health TRANSCRIPT
Dr. Michael Mbagwu, senior Medical Director at Verana Health, a real-world data company helping to accelerate clinical research using EHR data and other data to unlock insights about clinical practice patterns. The company is also addressing systematic bias in clinical trials by using real-world data and analyzing demographic information and geogra…
…
continue reading
E
Empowered Patient Podcast
1
Power of Real-World Data in Research and Clinical Practice with Dr. Michael Mbagwu Verana Health
20:46
20:46
Play later
Play later
Lists
Like
Liked
20:46
Dr. Michael Mbagwu, senior Medical Director at Verana Health, a real-world data company helping to accelerate clinical research using EHR data and other data to unlock insights about clinical practice patterns. The company is also addressing systematic bias in clinical trials by using real-world data and analyzing demographic information and geogra…
…
continue reading
D
Digital Politics with Karen Jagoda
1
View of the 2023 Virginia Election Results with Andrea Miller Center for Common Ground
23:38
23:38
Play later
Play later
Lists
Like
Liked
23:38
Andrea Miller, Center for Common Ground joins Deepak Puri, CEO of The Democracy Labs, to highlight the results of the recent election in Virginia and the impact of early voting on the outcome. As seen around the country, even school board races were contentious. Deepak and Andrea talk about: The variations in the Virginia election results in this d…
…
continue reading
E
Empowered Patient Podcast
1
Breaking Down Barriers and Addressing Disparities in Access to Quality Cancer Care with Dr. Todd Sachs AccessHope TRANSCRIPT
Dr. Todd Sachs, Chief Medical Officer at AccessHope, highlights why socioeconomic disparities in cancer mortality have widened. The key is access to screening tests, often limited by the cost and location of the testing facility. Geography also impacts access to sub-specialists with the most current information available. Todd emphasizes the import…
…
continue reading
E
Empowered Patient Podcast
1
Breaking Down Barriers and Addressing Disparities in Access to Quality Cancer Care with Dr. Todd Sachs AccessHope
21:57
21:57
Play later
Play later
Lists
Like
Liked
21:57
Dr. Todd Sachs, Chief Medical Officer at AccessHope, highlights why socioeconomic disparities in cancer mortality have widened. The key is access to screening tests, often limited by the cost and location of the testing facility. Geography also impacts access to sub-specialists with the most current information available. Todd emphasizes the import…
…
continue reading
E
Empowered Patient Podcast
1
Using Anti-TNF Therapy and Synthetic Cannabinoids for Pain and Inflammation with Dr. Jim Woody 180 Life Sciences TRANSCRIPT
Dr. Jim Woody, CEO and Director of 180 Life Sciences, discusses the company's vision for safer pain and inflammation management. Their earlier work on anti-TNF therapy revolutionized the treatment of conditions such as rheumatoid arthritis. Now 180 Life Sciences focuses on additional indications of inflammation, fibrosis, and cognitive dementia for…
…
continue reading
E
Empowered Patient Podcast
1
Using Anti-TNF Therapy and Synthetic Cannabinoids for Pain and Inflammation with Dr. Jim Woody 180 Life Sciences
19:14
19:14
Play later
Play later
Lists
Like
Liked
19:14
Dr. Jim Woody, CEO and Director of 180 Life Sciences, discusses the company's vision for safer pain and inflammation management. Their earlier work on anti-TNF therapy revolutionized the treatment of conditions such as rheumatoid arthritis. Now 180 Life Sciences focuses on additional indications of inflammation, fibrosis, and cognitive dementia for…
…
continue reading
E
Empowered Patient Podcast
1
Survey Reveals Preferences for Virtual Healthcare and Digital Solutions in Addition to Human Interaction with John Erwin Carenet Health TRANSCRIPT
John Erwin, CEO of Carenet Health, discusses their recent survey of patients and providers covered by commercial insurance companies or the government programs Medicare and Medicaid. While there is growing interest in using conversational texting and other digital tools, patients still want to talk with a human. The report reveals that Medicare/Med…
…
continue reading
E
Empowered Patient Podcast
1
Survey Reveals Preferences for Virtual Healthcare and Digital Solutions in Addition to Human Interaction with John Erwin Carenet Health
23:33
23:33
Play later
Play later
Lists
Like
Liked
23:33
John Erwin, CEO of Carenet Health, discusses their recent survey of patients and providers covered by commercial insurance companies or the government programs Medicare and Medicaid. While there is growing interest in using conversational texting and other digital tools, patients still want to talk with a human. The report reveals that Medicare/Med…
…
continue reading
E
Empowered Patient Podcast
1
Early Detection of Esophageal Cancer Using Groundbreaking Non-Invasive Test with Dr. Lishan Aklog Lucid Diagnostics TRANSCRIPT
Dr. Lishan Aklog, CEO of Lucid Diagnostics, discusses the current diagnostic landscape for esophageal cancer and the need for early detection. The current diagnostic tool, an upper endoscopy, is an invasive procedure requiring anesthesia. The EsoGuard, a noninvasive simple cell collection procedure, uses molecular diagnostics to detect pre-cancerou…
…
continue reading
E
Empowered Patient Podcast
1
Early Detection of Esophageal Cancer Using Groundbreaking Non-Invasive Test with Dr. Lishan Aklog Lucid Diagnostics
17:04
17:04
Play later
Play later
Lists
Like
Liked
17:04
Dr. Lishan Aklog, CEO of Lucid Diagnostics, discusses the current diagnostic landscape for esophageal cancer and the need for early detection. The current diagnostic tool, an upper endoscopy, is an invasive procedure requiring anesthesia. The EsoGuard, a noninvasive simple cell collection procedure, uses molecular diagnostics to detect pre-cancerou…
…
continue reading
E
Empowered Patient Podcast
1
Using Benefit-Risk Profile of Existing Cancer Drugs to Determine Optimal Regimen and New Formulations with David Young Processa Pharmaceuticals TRANSCRIPT
David Young, President of R&D at Processa Pharmaceuticals, talks about the FDA's Project Optimus draft guidance on optimal dosage regimens for specific patients. Processa is modifying existing cancer-killing molecules to improve efficacy and decrease side effects by taking into account genetic factors and the benefit-risk profile of each patient. T…
…
continue reading
E
Empowered Patient Podcast
1
Using Benefit-Risk Profile of Existing Cancer Drugs to Determine Optimal Regimen and New Formulations with David Young Processa Pharmaceuticals
19:49
19:49
Play later
Play later
Lists
Like
Liked
19:49
David Young, President of R&D at Processa Pharmaceuticals, talks about the FDA's Project Optimus draft guidance on optimal dosage regimens for specific patients. Processa is modifying existing cancer-killing molecules to improve efficacy and decrease side effects by taking into account genetic factors and the benefit-risk profile of each patient. T…
…
continue reading
E
Empowered Patient Podcast
1
Next-Generation T-Cell Therapy Recognizes Multiple Antigens Fights Tumor Resistance with Dr. Juan Vera Marker Therapeutics TRANSCRIPT
Dr. Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company, is developing next-generation immunotherapy with a multi-tumor-specific T-cell platform to overcome limitations of current T-cell therapies with narrow target recognition. This approach, which recognizes multiple antigens within the tumor, helps prevent tumor resis…
…
continue reading
E
Empowered Patient Podcast
1
Next-Generation T-Cell Therapy Recognizes Multiple Antigens Fights Tumor Resistance with Dr. Juan Vera Marker Therapeutics
19:17
19:17
Play later
Play later
Lists
Like
Liked
19:17
Dr. Juan Vera, CEO of Marker Therapeutics, a clinical-stage immuno-oncology company, is developing next-generation immunotherapy with a multi-tumor-specific T-cell platform to overcome limitations of current T-cell therapies with narrow target recognition. This approach, which recognizes multiple antigens within the tumor, helps prevent tumor resis…
…
continue reading
E
Empowered Patient Podcast
1
Developing Phosphatase Inhibitors to Treat Rare Neurodevelopmental Disorder with Andreas Grill DepYmed TRANSCRIPT
Andreas Grill, President and CEO of DepYmed, discusses protein tyrosine phosphatase-targeted drugs, a new class of drugs. With a focus on the specific enzyme PTP1B, DepYmed discovered orally bioavailable molecules that inhibit PTP1B, targeting the signal transaction pathway. They are initially testing to treat Rett syndrome, a rare disease with no …
…
continue reading
E
Empowered Patient Podcast
1
Developing Phosphatase Inhibitors to Treat Rare Neurodevelopmental Disorder with Andreas Grill DepYmed
19:57
19:57
Play later
Play later
Lists
Like
Liked
19:57
Andreas Grill, President and CEO of DepYmed, discusses protein tyrosine phosphatase-targeted drugs, a new class of drugs. With a focus on the specific enzyme PTP1B, DepYmed discovered orally bioavailable molecules that inhibit PTP1B, targeting the signal transaction pathway. They are initially testing to treat Rett syndrome, a rare disease with no …
…
continue reading
E
Empowered Patient Podcast
1
Using AI-Assisted Multi-Modal Data Analysis for Drug Development with Vin Singh Bullfrog AI TRANSCRIPT
Vin Singh, Founder and CEO of Bullfrog AI, discusses how AI is being used to improve the drug development process through a precision medicine approach that looks at a combination of genetic and non-genetic attributes to predict patient response to drugs. Bullfrog AI aims to reduce the failure rate in late-stage trials by enrolling the right patien…
…
continue reading
